Scalp Psoriasis

被引:0
作者
Kircik, Leon H. [1 ,2 ]
Kumar, Sandeep [3 ]
机构
[1] Mt Sinai Med Ctr, New York, NY 10029 USA
[2] Indiana Univ, Med Ctr, Indianapolis, IN USA
[3] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA
关键词
PROPIONATE SHAMPOO 0.05-PERCENT; COAL-TAR; BETAMETHASONE DIPROPIONATE; CALCIPOTRIOL; EFFICACY; FORMULATION; SAFETY;
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Psoriasis is a chronic, debilitating disease that commonly involves the scalp. Despite a wide range of therapy options, scalp psoriasis remains difficult to treat, highlighting a long-standing unmet need for the safe and effective treatment of scalp psoriasis. Many topical therapies for scalp psoriasis are also difficult or unpleasant to apply, resulting in decreased adherence and efficacy. In brief, the high level of patient dissatisfaction with currently available treatments for psoriasis supports the need for new, effective and well-tolerated treatment options for scalp psoriasis. This article aims to review the efficacy and safety of new formulations and treatment options available to control scalp psoriasis. For example, a new formulation of calcipotriene/betamethasone scalp solution has a rapid onset of action with once daily dosing that improves compliance. The CalePso study examines the safety profile of otherwise established Clobetasol propionate (CP) shampoo 0.05%, and reports that CP shampoo is safe and efficacious in the long-term management of scalp psoriasis. A new foam formulation of coal tar is shown to be cosmetically acceptable and easier to apply.
引用
收藏
页码:S101 / S105
页数:5
相关论文
共 23 条
[1]   Tar [J].
Arnold, WP .
CLINICS IN DERMATOLOGY, 1997, 15 (05) :739-744
[2]  
Barnes L, 2000, EUR J DERMATOL, V10, P199
[3]  
Cunliffe WJ, 1999, DERMATOLOGY, V198, P405
[4]   A new calcipotriol/beta methasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris [J].
Douglas, WS ;
Poulin, Y ;
Decroix, J ;
Ortonne, JP ;
Mrowietz, U ;
Gulliver, W ;
Krogstad, AL ;
Larsen, FG ;
Iglesias, L ;
Buckley, C ;
Bibby, AJ .
ACTA DERMATO-VENEREOLOGICA, 2002, 82 (02) :131-135
[5]   The prevalence of psoriasis in African Americans: Results from a population-based study [J].
Gelfand, JM ;
Stern, RS ;
Nijsten, T ;
Feldman, SR ;
Thomas, J ;
Kist, J ;
Rolstad, T ;
Margolis, DJ .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (01) :23-26
[6]   COMPARATIVE EFFECTS OF CALCIPOTRIOL (MC903) SOLUTION AND PLACEBO (VEHICLE OF MC903) IN THE TREATMENT OF PSORIASIS OF THE SCALP [J].
GREEN, C ;
GANPULE, M ;
HARRIS, D ;
KAVANAGH, G ;
KENNEDY, C ;
MALLETT, R ;
RUSTIN, M ;
DOWNES, N .
BRITISH JOURNAL OF DERMATOLOGY, 1994, 130 (04) :483-487
[7]   EFFICACY OF TOPICAL 5-PERCENT LIQUOR CARBONIS-DETERGENS VS ITS EMOLLIENT BASE IN THE TREATMENT OF PSORIASIS [J].
KANZLER, MH ;
GORSULOWSKY, DC .
BRITISH JOURNAL OF DERMATOLOGY, 1993, 129 (03) :310-314
[8]  
*LLC, 2008, TACL SCALP PACK INS
[9]   A Study of the Safety and Efficacy of Calcipotriol and Betamethasone Dipropionate Scalp Formulation in the Long-Term Management of Scalp Psoriasis [J].
Luger, T. A. ;
Cambazard, F. ;
Larsen, F. G. ;
Bourcier, M. ;
Gupta, G. ;
Clonier, F. ;
Kidson, P. ;
Shear, N. H. .
DERMATOLOGY, 2008, 217 (04) :321-328
[10]   Topical preparations for the treatment of psoriasis: a systematic review [J].
Mason, J ;
Mason, AR ;
Cork, MJ .
BRITISH JOURNAL OF DERMATOLOGY, 2002, 146 (03) :351-364